Role of pathologic isoforms of intracellular Aβ in neurodegeneration
ABG-129158 | Thesis topic | |
2025-03-05 | Public funding alone (i.e. government, region, European, international organization research grant) |

- Psychology, neurosciences
- Biology
- Health, human and veterinary medicine
Topic description
The NeuroSchool PhD Program of Aix-Marseille University (France) has launched its annual calls for PhD contracts for students with a master's degree in a non-French university and for international co-supervised PhDs.
This project is one of the proposed projects. Not all proposed projects will be funded, check our website for details.
State of the art - Despite significant efforts by the global scientific community to unravel the molecular mechanisms of Alzheimer’s disease (AD) over the past decades, the primary event triggering neurodegeneration remains elusive. Increasing evidence suggests that intracellular Amyloid-β (iAβ) plays a pivotal role in the early stages of AD development (Gallego Villarejo et al. 2022). Notably, iAβ directly interacts with another key protein implicated in AD—Tau (Zhang et al. 2021), which, in its hyperphosphorylated state, detaches from tubulin microtubules (MT), leading to their depolymerization. Recent findings indicate that iAβ facilitates Tau cross-seeding, further promoting its aggregation (Tripathi and Khan 2020). Additionally, several pathogenic mutations, such as those associated with the Tottori and English familial AD variants, along with specific post-translational modifications (e.g., Asp7 isomerization and Ser8 phosphorylation), have been shown to enhance Aβ aggregation, potentially exacerbating disease progression (Tsvetkov et al. 2008; Kozin et al. 2015; Kulikova et al. 2014).
Objectives - The primary objective of this PhD project is to elucidate the role of pathogenic forms of iAβ in the early stages of AD at the cellular level. Specifically, the study aims to investigate the impact of iAβ on its interaction with Tau, the subsequent aggregation processes, and their effect on MT stability. Methods - To achieve the objectives of this project, we will employ a combination of in vitro and cell-based approaches. The impact of pathogenic iAβ on its interaction with Tau will be investigated using ITC to quantify binding affinity and thermodynamics. The aggregation process will be studied using DLS, TEM, and ThS fluorescence to assess fibrillization and oligomerization. To evaluate the consequences of these events on MT stability and dynamics, we will analyze tubulin polymerization in vitro using DSF and turbidimetry. Additionally, cell-based colocalization experiments, including FRET microscopy, will be performed to investigate direct interactions between Tau, iAβ, and tubulin in cellular models.
Expected results - This project is expected to provide new insights into the role of pathogenic forms of iAβ in the early stages of AD. We anticipate clarifying how iAβ interacts with Tau, how this interaction influences Tau aggregation, and how these events affect MT stability and dynamics. Our findings should reveal whether specific mutations or post-translational modifications of iAβ enhance its pathological interactions with Tau, leading to MT destabilization. Furthermore, we expect to identify key molecular mechanisms underlying these processes, which may contribute to the development of new therapeutic strategies aimed at targeting intracellular amyloid-related toxicity in AD.
Feasibility - The laboratory has all necessary equipment and extensive expertise in protein interactions, aggregation dynamics, and MT stability, ensuring the successful execution of the project.
Starting date
Funding category
Funding further details
Presentation of host institution and host laboratory
Within Aix Marseille Université, NeuroMarseille brings together 8 research laboratories and NeuroSchool, a graduate school in neuroscience, to increase the attractiveness of the university, international collaborations, interdisciplinarity, links with the clinical and industrial worlds and the integration of students into professional life.
Launched in July 2018, NeuroSchool unifies and harmonizes the training of the third year of the Bachelor of Life Sciences (Neuroscience track), the Master's and the PhD in Neuroscience.
PhD title
Country where you obtained your PhD
Institution awarding doctoral degree
Graduate school
Candidate's profile
- Master's degree from a non-French university in neuroscience or related field
- Fluent in English
The ideal candidate should be curious, proactive, and eager to learn, possess a good level in English or French, and demonstrate a willingness to develop expertise in both biophysical methods and cell-based experiments, along with good manual skills and attention to detail.
Vous avez déjà un compte ?
Nouvel utilisateur ?
Get ABG’s monthly newsletters including news, job offers, grants & fellowships and a selection of relevant events…
Discover our members
ADEME
CESI
MabDesign
TotalEnergies
Laboratoire National de Métrologie et d'Essais - LNE
ASNR - Autorité de sûreté nucléaire et de radioprotection - Siège
ANRT
PhDOOC
Groupe AFNOR - Association française de normalisation
MabDesign
SUEZ
Aérocentre, Pôle d'excellence régional
Nokia Bell Labs France
ONERA - The French Aerospace Lab
Ifremer
Généthon
CASDEN
Tecknowmetrix
Institut Sup'biotech de Paris
-
JobPermanentRef. ABG129192Association Bernard Gregory (ABG)Paris (3ème) - Ile-de-France - France
Business Developer (F/H)
Open to all scientific expertisesAny -
JobPermanentRef. ABG128969Institut Polytechnique des Sciences Avancées - IPSAToulouse - Occitanie - France
Enseignant-chercheur en Mécanique des fluides numérique
Open to all scientific expertisesAny